Immunotherapy-on-Chip Against an Experimental Sepsis Model

Volume: 44, Issue: 6, Pages: 2333 - 2345
Published: Aug 20, 2021
Abstract
Lipopolysaccharide (LPS) is commonly used in murine sepsis models, which are largely associated with immunosuppression and collapse of the immune system. After adapting the LPS treatment to the needs of locally bred BALB/c mice, the present study explored the protective role of Micrococcus luteus peptidoglycan (PG)-pre-activated vaccine-on-chip technology in endotoxemia. The established protocol consisted of five daily intraperitoneal injections...
Paper Details
Title
Immunotherapy-on-Chip Against an Experimental Sepsis Model
Published Date
Aug 20, 2021
Volume
44
Issue
6
Pages
2333 - 2345
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.